Cargando…

The prognostic value of integration of pretreatment serum amyloid A (SAA)–EBV DNA (S-D) grade in patients with nasopharyngeal carcinoma

BACKGROUND: Serum amyloid A (SAA) has been associated with the development and prognosis of cancer. The purpose of this study was to evaluate the predictive value of integration of pretreatment SAA–EBV DNA (S-D) grade and comparison with the TNM staging system in patients with nasopharyngeal carcino...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianpei, Lai, Changchun, Peng, Songguo, Chen, Hao, Zhou, Lei, Chen, Yufeng, Chen, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944720/ https://www.ncbi.nlm.nih.gov/pubmed/31907639 http://dx.doi.org/10.1186/s40169-019-0252-7

Ejemplares similares

Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics
por: Li, Jianpei, et al.
Publicado: (2018)

Evaluation of an in-clinic Serum Amyloid A (SAA) assay and assessment of the effects of storage on SAA samples
por: Hillström, Anna, et al.
Publicado: (2010)

High-Density Lipoproteins and Serum Amyloid A (SAA)
por: Webb, Nancy R.
Publicado: (2021)

Some properties of antisera to serum amyloid A protein (SAA): inhibition of precipitation by complexing of SAA to albumin
Publicado: (1976)

Characterization of rat serum amyloid A4 (SAA4): A novel member of the SAA superfamily
por: Rossmann, Christine, et al.
Publicado: (2014)

Serum amyloid A (SAA) concentration in cats with gastrointestinal lymphoma
por: AKIYOSHI, Makoto, et al.
Publicado: (2023)

Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1
por: Abouelasrar Salama, Sara, et al.
Publicado: (2020)

Evaluation of a Commercially Available Human Serum Amyloid A (SAA) Turbidimetric Immunoassay for Determination of Feline SAA Concentration
por: Hansen, A. E., et al.
Publicado: (2006)

Amyloid-related serum protein SAA in endotoxin-induced amyloidosis of the mink
Publicado: (1976)

Serum amyloid A1 (SAA1) protein in human colostrum
por: Sack, George H., et al.
Publicado: (2018)

Changes in Serum Amyloid A (SAA) and 8-OHdG in Patients with Senile Early Cognitive Impairment
por: Cao, Xiaohong, et al.
Publicado: (2020)

Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era
por: Tan, Xi-Rong, et al.
Publicado: (2021)

The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis
por: Liu, Weixing, et al.
Publicado: (2021)

The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma
por: Yan, Dan-Fang, et al.
Publicado: (2017)

Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
por: Cocco, E, et al.
Publicado: (2009)

Measuring Biochemical Variables and Serum Amyloid A (SAA) in Working Mules in Central Italy
por: Bazzano, Marilena, et al.
Publicado: (2022)

Pretreatment Plasma EBV-DNA Load Guides Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Cancer: A Meta-Analysis
por: Lai, Lin, et al.
Publicado: (2021)

Connective tissue origin of the amyloid-related protein SAA
Publicado: (1976)

A multi-parametric prognostic model based on clinical features and serological markers predicts overall survival in non-small cell lung cancer patients with chronic hepatitis B viral infection
por: Chen, Shulin, et al.
Publicado: (2020)

Human Serum Amyloid A3 (SAA3) Protein, Expressed as a Fusion Protein with SAA2, Binds the Oxidized Low Density Lipoprotein Receptor
por: Tomita, Takeshi, et al.
Publicado: (2015)

Serum amyloid A (SAA) concentration after training sessions in Arabian race and endurance horses
por: Cywinska, Anna, et al.
Publicado: (2013)

Serum amyloid A (SAA) and Interleukin-6 (IL-6) as the potential biomarkers for gastric cancer
por: Hou, Yongwang, et al.
Publicado: (2022)

Prognostic Value of Regression Rate of Plasma EBV DNA After Induction Chemotherapy for Stage II-IVA Nasopharyngeal Carcinoma
por: Peng, Hao, et al.
Publicado: (2021)

Establishment and Validation of Nomogram Based on Combination of Pretreatment C-Reactive Protein/Albumin Ratio–EBV DNA Grade in Nasopharyngeal Carcinoma Patients Who Received Concurrent Chemoradiotherapy
por: Huang, Zhang-Zan, et al.
Publicado: (2021)

Picroside II Isolated from Pseudolysimachion rotundum var. subintegrum Inhibits Glucocorticoid Refractory Serum Amyloid A (SAA) Expression and SAA-induced IL-33 Secretion
por: Lee, Kiram, et al.
Publicado: (2019)

Pretreatment Serum Amyloid A and C-reactive Protein Comparing with Epstein-Barr Virus DNA as Prognostic Indicators in Patients with Nasopharyngeal Carcinoma: A Prospective Study
por: Chen, Qiu-Yan, et al.
Publicado: (2018)

Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma
por: Mo, Hao-Yuan, et al.
Publicado: (2012)

Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats
por: TEI, Meina, et al.
Publicado: (2017)

Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma
por: Ou, Guoping, et al.
Publicado: (2019)

Effects of oral maintenance chemotherapy and predictive value of circulating EBV DNA in metastatic nasopharyngeal carcinoma
por: Zhou, Han, et al.
Publicado: (2020)

Changes in Serum Amyloid A (SAA) Concentration in Arabian Endurance Horses During First Training Season
por: Witkowska-Piłaszewicz, Olga, et al.
Publicado: (2019)

Study of role of serum amyloid A (SAA) as a marker of disease activity in juvenile idiopathic arthritis
por: Dev, Sharad, et al.
Publicado: (2019)

Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection
por: Chen, Shulin, et al.
Publicado: (2018)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers
por: Lai, Changchun, et al.
Publicado: (2021)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Prognostic value of pretreatment (18)F-FDG PET-CT for nasopharyngeal carcinoma patients
por: Huang, Yecai, et al.
Publicado: (2017)

Increased pretreatment levels of serum LDH and ALP as poor prognostic factors for nasopharyngeal carcinoma
por: Li, Guo, et al.
Publicado: (2012)

Investigation of the solubility and the potentials for purification of serum amyloid A (SAA) from equine acute phase serum – a pilot study
por: Christensen, Michelle B, et al.
Publicado: (2013)

Detoxification of Corncob Acid Hydrolysate with SAA Pretreatment and Xylitol Production by Immobilized Candida tropicalis
por: Deng, Li-Hong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hao6cud3hl1fh76s1rm1bp8tb8